SNNAQ (Sienna Biopharmaceuticals) Institutional Ownership: 13.41% (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Sienna Biopharmaceuticals Institutional Ownership?

Sienna Biopharmaceuticals SNNAQ -99.00% Institutional Ownership is 13.41% as of Aug. 06, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sienna Biopharmaceuticals's institutional ownership is 13.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sienna Biopharmaceuticals's Insider Ownership is 8.32%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sienna Biopharmaceuticals's Float Percentage Of Total Shares Outstanding is 64.23%.

Sienna Biopharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Institutional Ownership Chart

Sienna Biopharmaceuticals Historical Data

The historical data trend for Sienna Biopharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 13.47 13.47 13.47 13.47 13.47 13.47 13.47 13.47 12.27 12.27

Sienna Biopharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 13.41% mean?
Sienna Biopharmaceuticals (SNNAQ) has a Institutional Ownership of 13.41% as of Aug. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Institutional Ownership too high?
Sienna Biopharmaceuticals' current Institutional Ownership is 13.41%.
How does Sienna Biopharmaceuticals' Institutional Ownership compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Institutional Ownership of 13.41% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Institutional Ownership is 13.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Institutional Ownership of 13.41%. The current Institutional Ownership is 13.41%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Institutional Ownership is 13.41% as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.